- Home
- VYNE vs BCG Comparison
VYNE vs BCG Comparison
Compare VYNE & BCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- BCG
- Stock Information
- Founded
- VYNE 2003
- BCG 2016
- Country
- VYNE United States
- BCG United States
- Employees
- VYNE N/A
- BCG N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- BCG
- Sector
- VYNE Health Care
- BCG
- Exchange
- VYNE Nasdaq
- BCG Nasdaq
- Market Cap
- VYNE 41.9M
- BCG 42.3M
- IPO Year
- VYNE 2018
- BCG N/A
- Fundamental
- Price
- VYNE $2.32
- BCG $2.03
- Analyst Decision
- VYNE Strong Buy
- BCG
- Analyst Count
- VYNE 2
- BCG 0
- Target Price
- VYNE $6.88
- BCG N/A
- AVG Volume (30 Days)
- VYNE 129.4K
- BCG 51.7K
- Earning Date
- VYNE 02-27-2025
- BCG 02-26-2025
- Dividend Yield
- VYNE N/A
- BCG N/A
- EPS Growth
- VYNE N/A
- BCG N/A
- EPS
- VYNE N/A
- BCG N/A
- Revenue
- VYNE $493,000.00
- BCG $161,721,000.00
- Revenue This Year
- VYNE $28.30
- BCG N/A
- Revenue Next Year
- VYNE N/A
- BCG N/A
- P/E Ratio
- VYNE N/A
- BCG N/A
- Revenue Growth
- VYNE 39.27
- BCG N/A
- 52 Week Low
- VYNE $1.57
- BCG $1.85
- 52 Week High
- VYNE $4.30
- BCG $16.61
- Technical
- Relative Strength Index (RSI)
- VYNE 36.13
- BCG N/A
- Support Level
- VYNE $2.34
- BCG N/A
- Resistance Level
- VYNE $3.00
- BCG N/A
- Average True Range (ATR)
- VYNE 0.27
- BCG 0.00
- MACD
- VYNE -0.08
- BCG 0.00
- Stochastic Oscillator
- VYNE 8.24
- BCG 0.00
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About BCG Binah Capital Group Inc. Common Stock
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.